Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Lee, Heock ^a   Um, Soo Jung ^a   Kim, Yun Seong ^b   Kim, Deog Kyeom ^c   Jang, An Soo ^d   Choi, Hye Sook ^e   Kim, Yee Hyung ^f   Kim, Tae Eun ^g   Yoo, Kwang Ha ^g   Jung, Ki Suck ^h  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Dongguk University Gyeongju Hospital   (South Korea)

^f Kyung Hee University College of Medicine   (South Korea)

^g Konkuk University School of Medicine   (South Korea)

^h Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTION; PROGNOSIS; RESPIRATORY AIRFLOW; RISK ASSESSMENT; RISK FACTOR; BLOOD; CYTOLOGY; HOSPITAL; LUNG; LYMPHOCYTE; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

FEMALE; HOSPITALS; HUMANS; LUNG; LYMPHOCYTES; MALE; NEUTROPHILS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84973480479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156511     Document Type: Article

References (29)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370:765-773. PMID: 17765526
2. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2:258-268. PMID: 16267346
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease updated 2015 Available:http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
4. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF Jr, Lipinska I, et al. Systemic inflammation and COPD: the Framingham Heart Study. Chest. 2008; 133:19-25. PMID: 17908709
5. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175:250-255. PMID: 17053205
6. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186:982-988. doi: 10.1164/rccm.201206-1113OC PMID: 22983959
7. Han YC, Yang TH, Kim DI, Jin HY, Chung SR, Seo JS, et al. Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J. 2013; 43:93-99. doi: 10.4070/kcj.2013.43.2.93 PMID: 23508782
8. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106:dju124. doi: 10.1093/jnci/dju124 PMID: 24875653
9. Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med. 2013; 33:105-110. doi: 10.3343/alm.2013.33.2.105 PMID: 23482854
10. Gunay E, Sarinc Ulasli S, Akar O, Ahsen A, Gunay S, Koyuncu T, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014; 37:374-380. doi: 10.1007/s10753-013-9749-1 PMID: 24078279
11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-338. PMID: 16055882
12. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166:111-117. PMID: 12091180
13. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54:581-586. PMID: 10377201
14. Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Leidy NK. Development and first validation of the COPD assessment test. Eur Respr J. 2009; 34:648-654.
15. Meguro M, Barley EA, Spencer S, Jones PW. Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest. 2007; 132:456-463. PMID: 17646240
16. Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012; 7:e37483. doi: 10.1371/journal.pone.0037483 PMID: 22624038
17. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF Jr., Lipinska I, et al. Systemic inflammation and COPD: the Framingham Heart Study. Chest. 2008; 133:19-25. PMID: 17908709
18. Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA. 2013; 309:2353-2361. doi: 10.1001/jama.2013.5732 PMID: 23757083
19. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363:1128-1138. doi: 10.1056/NEJMoa0909883 PMID: 20843247
20. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 185:1065-1072. doi: 10.1164/rccm.201110-1792OC PMID: 22427534
21. Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2015; 42:383-391.
22. Sørensen AK, Holmgaard DB, Mygind LH, Johansen J, Pedersen C. Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality-a cohort study. J Inflamm. 2015; 12:20.
23. Furuate R, Ishii T, Motegi T, Hattori K, Kusunoki Y, Gemma A, et al. The neutrophil to lymphocyte ratio is related to disease severity and exacerbation in patients with chronic obstructive pulmonary disease. Intern Med 2016; 55:223-229. doi: 10.2169/internalmedicine.55.5772 PMID: 26831014
24. Taylan M, Demir M, Kaya H, Selimoglu Sen H, Abakay O, Carkanat AI, et al. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Clin Respir J. In press. doi: 10.1111/crj.12336
25. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5:478-485. doi: 10.1513/pats.200802-014ET PMID: 18453359
26. StǍnescu D, Sanna A, Veriter C, Kostianev S, Calcagni PG, Fabbri LM, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267-271. PMID: 8779129
27. Gray RD, Imrie M, Boyd AC, Porteous D, Innes JA, Greening AP. Sputum and serum calprotectin are useful biomarkers during CF exacerbation. J Cystic Fibrosis. 2010; 9(3):193-8.
28. Milara J, Juan G, Peiro T, Serrano A, Cortijo J. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy. Respiration. 2012; 83:147-158. doi: 10.1159/000332834 PMID: 22094549
29. Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med 2002; 166: 1078-83. PMID: 12379551